[ Inside the business ]

CNC stock analysis

CNC · Centene Corp

Hospital and medical service plans. Growing 2%. Keeps 0¢ of every dollar.

Watch: growth that has stopped speeding up.

The future, in 7 questions

Priced in: under 0.1× sales in 5 yrs. Evidence: sales +2% · 0¢ profit/$1.

01 What's priced in?under 0.1× sales in 5 yrs
Sales now$203.9B
Needed in 5 yrs$12.7B
02 Is the wave rising?No Radar technology matched

Not among the companies mentioning Radar's technologies most.

03 Will customers keep buying?Sales +2%, steady
No customer over 10%
Prepaid $680MSales +2%, steady
04 Is it scarce?No
PricingBacklogPrepaidSell-outTight
05 More profit per sale?Keeps 0¢ per $1
'21'22'23'24'250¢
Before running costs: 12% → 7%
06 Can it fund itself?Pays its own way
05 yrsself-funded
Shares −4.9%/yrDebt $15.5B
07 What could break it?2 to watch
  • Growth peaked
  • Insiders sold $12M outside pre-set plans

From SEC filings, price and Radar. Not advice.

The record

Early signals

Growth peaked.

Sales growth +7%, +10%, then +2% vs. a year ago.

What could go wrong

Steadier than most.

It has moved 0.8× the market. In the 2008 crisis it fell 27% while the market fell 51%. Debt is covered by cash.

Speculative check

Not classified.

Not Self-funding because of: loss in the latest quarter.

What they sell

98% Health Care, Premium.

Health Care, Premium 98% · Service 2% (latest quarter)

Where each dollar goes

0¢ profit.

1¢ to make what it sells, 98¢ on research and overhead, 0¢ left over. Revenue $203.9B in the last 12 months.

Its market

1.0× the economy.

The government expects its industry, insurance carriers, to grow 2.0% a year to 2035, vs. 2.0% for the whole economy.

Market size and share

Your call.

There's no official size for its market. Enter one you trust to see its share, and slide to see what a bigger share would mean.

Life cycle

Shake-out.

Its cash flows are mixed, typical of a company in transition.

Earnings quality

Can't score.

Not available: some of the eight inputs aren't in the company's structured filings (common for banks, insurers and companies without a cost of goods line).

Competitive advantage

1 of 10 years.

Returns beat its 7.5% cost of capital in 1 of the last 10 years. Gross margin went from 95% to 7%.

Future bets

0% on equipment.

$781M a year on equipment and buildings.

All figures from Centene Corp's SEC filings (EDGAR) unless tagged otherwise. Educational only, not investment advice.